Pluristem Therapeutics Inc.’s cell therapy products are designed to treat patients by stimulating their bodies’ own regenerative mechanisms

  • Clinical Programs

  • Products

  • Science & Technology

  • Benefits

    Technology platform for cell products, targeting treatment for a range of indications

  • Cell profiling expertise

    Deep understanding of the cell secretion profiles that generate therapeutic effects

  • Manufacturing facility

    Company-owned and operated GMP-certified manufacturing and research facilities


  • 04/04/2019Pluristem Therapeutics Inc. Announces Pricing of Its Public Offering and Registered Direct Offering for Aggregate Proceeds of Approximately $20 Million

    Read More